14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.92 $1.42 Tuesday, 23rd Apr 2024 BLUE stock ended at $0.97. This is 1.78% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.09% from a day low at $0.95 to a day high of $1.05.
90 days $0.88 $1.92
52 weeks $0.88 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Apr 23, 2024 $0.96 $1.05 $0.95 $0.97 4 770 050
Apr 22, 2024 $1.01 $1.03 $0.94 $0.95 4 321 393
Apr 19, 2024 $0.95 $1.03 $0.94 $1.02 8 136 181
Apr 18, 2024 $0.96 $1.01 $0.92 $0.95 6 503 198
Apr 17, 2024 $0.96 $1.03 $0.95 $0.96 8 653 228
Apr 16, 2024 $1.04 $1.07 $0.98 $0.99 5 515 737
Apr 15, 2024 $1.11 $1.12 $1.01 $1.03 6 835 560
Apr 12, 2024 $1.15 $1.19 $1.07 $1.10 6 441 114
Apr 11, 2024 $1.21 $1.23 $1.14 $1.16 3 480 277
Apr 10, 2024 $1.21 $1.21 $1.16 $1.19 3 657 923
Apr 09, 2024 $1.17 $1.26 $1.15 $1.26 3 776 151
Apr 08, 2024 $1.23 $1.23 $1.15 $1.16 3 910 102
Apr 05, 2024 $1.23 $1.27 $1.19 $1.23 2 553 502
Apr 04, 2024 $1.19 $1.27 $1.18 $1.23 4 092 074
Apr 03, 2024 $1.18 $1.22 $1.16 $1.18 3 266 409
Apr 02, 2024 $1.22 $1.25 $1.16 $1.21 4 409 619
Apr 01, 2024 $1.29 $1.30 $1.22 $1.24 3 054 893
Mar 28, 2024 $1.35 $1.42 $1.25 $1.28 7 216 897
Mar 27, 2024 $1.19 $1.39 $1.15 $1.37 6 847 492
Mar 26, 2024 $1.19 $1.21 $1.07 $1.20 18 133 395
Mar 25, 2024 $1.38 $1.42 $1.35 $1.36 4 385 659
Mar 22, 2024 $1.45 $1.45 $1.33 $1.37 5 557 798
Mar 21, 2024 $1.41 $1.49 $1.38 $1.46 5 829 490
Mar 20, 2024 $1.40 $1.43 $1.36 $1.40 3 805 441
Mar 19, 2024 $1.44 $1.45 $1.36 $1.40 5 975 994
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT